 Robert Wilson
Concepts (496)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 111 | 2019 | 1038 | 13.910 |
Why?
| | Aging | 86 | 2019 | 1319 | 11.220 |
Why?
| | Alzheimer Disease | 102 | 2019 | 1492 | 9.960 |
Why?
| | Cognition | 75 | 2019 | 916 | 8.260 |
Why?
| | Dementia | 29 | 2019 | 452 | 6.700 |
Why?
| | Longitudinal Studies | 109 | 2019 | 1216 | 6.130 |
Why?
| | Aged, 80 and over | 190 | 2019 | 4580 | 6.100 |
Why?
| | Aged | 223 | 2019 | 8962 | 5.560 |
Why?
| | Brain | 50 | 2019 | 1304 | 5.230 |
Why?
| | Neuropsychological Tests | 96 | 2019 | 1182 | 5.110 |
Why?
| | European Continental Ancestry Group | 44 | 2018 | 532 | 4.380 |
Why?
| | Male | 238 | 2019 | 15627 | 4.370 |
Why?
| | Female | 235 | 2019 | 16022 | 4.270 |
Why?
| | Memory | 23 | 2018 | 314 | 3.670 |
Why?
| | Humans | 255 | 2019 | 26828 | 3.610 |
Why?
| | Depression | 21 | 2016 | 441 | 3.380 |
Why?
| | Olfaction Disorders | 7 | 2019 | 38 | 3.230 |
Why?
| | African Americans | 34 | 2018 | 638 | 3.210 |
Why?
| | Personality | 7 | 2015 | 56 | 2.690 |
Why?
| | Lewy Bodies | 9 | 2019 | 159 | 2.650 |
Why?
| | Memory Disorders | 11 | 2019 | 165 | 2.620 |
Why?
| | Disease Progression | 32 | 2019 | 765 | 2.570 |
Why?
| | DNA-Binding Proteins | 9 | 2019 | 239 | 2.500 |
Why?
| | Cohort Studies | 55 | 2019 | 1681 | 2.450 |
Why?
| | Stress, Psychological | 9 | 2014 | 248 | 2.340 |
Why?
| | Memory, Episodic | 7 | 2019 | 85 | 2.170 |
Why?
| | Educational Status | 18 | 2019 | 248 | 2.040 |
Why?
| | Apolipoproteins E | 18 | 2018 | 176 | 1.930 |
Why?
| | Risk Factors | 60 | 2018 | 2316 | 1.920 |
Why?
| | Follow-Up Studies | 40 | 2019 | 1868 | 1.810 |
Why?
| | Mortality | 10 | 2019 | 73 | 1.720 |
Why?
| | Interpersonal Relations | 8 | 2014 | 112 | 1.720 |
Why?
| | Chicago | 38 | 2019 | 836 | 1.680 |
Why?
| | Hospitalization | 5 | 2019 | 286 | 1.650 |
Why?
| | Cerebral Infarction | 8 | 2015 | 144 | 1.640 |
Why?
| | Motor Activity | 18 | 2015 | 376 | 1.590 |
Why?
| | Neurodegenerative Diseases | 3 | 2018 | 86 | 1.570 |
Why?
| | Geriatric Assessment | 24 | 2017 | 212 | 1.540 |
Why?
| | Apolipoprotein E4 | 18 | 2018 | 180 | 1.530 |
Why?
| | African Continental Ancestry Group | 15 | 2018 | 160 | 1.450 |
Why?
| | Activities of Daily Living | 23 | 2013 | 418 | 1.440 |
Why?
| | Anxiety | 4 | 2013 | 129 | 1.400 |
Why?
| | Neurofibrillary Tangles | 10 | 2017 | 165 | 1.390 |
Why?
| | Health Literacy | 5 | 2018 | 68 | 1.380 |
Why?
| | Learning | 2 | 2018 | 86 | 1.370 |
Why?
| | Parkinsonian Disorders | 9 | 2019 | 155 | 1.370 |
Why?
| | Memory, Short-Term | 6 | 2019 | 81 | 1.350 |
Why?
| | Incidence | 28 | 2019 | 724 | 1.290 |
Why?
| | Neurotic Disorders | 6 | 2018 | 19 | 1.280 |
Why?
| | Proportional Hazards Models | 23 | 2019 | 339 | 1.240 |
Why?
| | Loneliness | 6 | 2018 | 41 | 1.210 |
Why?
| | Agnosia | 2 | 2016 | 10 | 1.140 |
Why?
| | Age Factors | 23 | 2019 | 833 | 1.130 |
Why?
| | Neurons | 4 | 2013 | 367 | 1.120 |
Why?
| | Perception | 3 | 2019 | 78 | 1.120 |
Why?
| | Disabled Persons | 7 | 2019 | 88 | 1.110 |
Why?
| | Autopsy | 12 | 2019 | 246 | 1.080 |
Why?
| | Middle Aged | 43 | 2018 | 10136 | 1.070 |
Why?
| | Independent Living | 9 | 2019 | 137 | 1.010 |
Why?
| | Genetic Predisposition to Disease | 12 | 2017 | 431 | 1.000 |
Why?
| | Hispanic Americans | 5 | 2015 | 167 | 0.990 |
Why?
| | Hippocampus | 5 | 2019 | 256 | 0.980 |
Why?
| | Amyloid beta-Peptides | 5 | 2017 | 193 | 0.970 |
Why?
| | Language | 3 | 2014 | 65 | 0.970 |
Why?
| | Research Design | 4 | 2014 | 189 | 0.950 |
Why?
| | Neocortex | 2 | 2019 | 36 | 0.940 |
Why?
| | Risk | 18 | 2018 | 205 | 0.940 |
Why?
| | Olfactory Bulb | 1 | 2019 | 13 | 0.920 |
Why?
| | Child Abuse | 2 | 2012 | 27 | 0.920 |
Why?
| | Anxiety Disorders | 3 | 2016 | 174 | 0.880 |
Why?
| | Chronic Disease | 5 | 2017 | 485 | 0.870 |
Why?
| | Nervous System Diseases | 4 | 2019 | 124 | 0.870 |
Why?
| | Cognitive Reserve | 1 | 2019 | 21 | 0.870 |
Why?
| | Genotype | 18 | 2018 | 410 | 0.830 |
Why?
| | Decision Making | 6 | 2019 | 183 | 0.820 |
Why?
| | United States | 26 | 2019 | 2119 | 0.800 |
Why?
| | Psychiatric Status Rating Scales | 12 | 2016 | 378 | 0.800 |
Why?
| | Reading | 4 | 2016 | 36 | 0.780 |
Why?
| | Prospective Studies | 27 | 2019 | 1597 | 0.780 |
Why?
| | Awareness | 4 | 2019 | 49 | 0.780 |
Why?
| | Brain Stem | 2 | 2016 | 24 | 0.760 |
Why?
| | Ambulatory Care | 1 | 2017 | 82 | 0.750 |
Why?
| | Psychomotor Performance | 8 | 2019 | 218 | 0.750 |
Why?
| | Death | 3 | 2019 | 27 | 0.740 |
Why?
| | Locus Coeruleus | 2 | 2013 | 23 | 0.740 |
Why?
| | Comorbidity | 14 | 2018 | 493 | 0.730 |
Why?
| | Urban Population | 4 | 2013 | 139 | 0.730 |
Why?
| | Depressive Disorder | 4 | 2019 | 214 | 0.730 |
Why?
| | Mobility Limitation | 7 | 2019 | 82 | 0.710 |
Why?
| | Brain Chemistry | 1 | 2016 | 48 | 0.700 |
Why?
| | Longevity | 2 | 2013 | 33 | 0.680 |
Why?
| | Motor Skills | 2 | 2013 | 48 | 0.680 |
Why?
| | Plaque, Amyloid | 7 | 2017 | 135 | 0.670 |
Why?
| | Exercise | 6 | 2019 | 340 | 0.670 |
Why?
| | Depressive Disorder, Major | 1 | 2016 | 99 | 0.660 |
Why?
| | Music | 1 | 2014 | 16 | 0.640 |
Why?
| | Alleles | 12 | 2018 | 199 | 0.640 |
Why?
| | Multilingualism | 1 | 2014 | 18 | 0.630 |
Why?
| | Quality of Life | 3 | 2015 | 527 | 0.630 |
Why?
| | Frail Elderly | 5 | 2014 | 42 | 0.630 |
Why?
| | Lewy Body Disease | 5 | 2018 | 82 | 0.620 |
Why?
| | Severity of Illness Index | 15 | 2019 | 1135 | 0.620 |
Why?
| | Mesencephalon | 1 | 2013 | 48 | 0.600 |
Why?
| | Disability Evaluation | 12 | 2015 | 308 | 0.580 |
Why?
| | Personal Satisfaction | 1 | 2013 | 43 | 0.570 |
Why?
| | Membrane Transport Proteins | 3 | 2017 | 45 | 0.570 |
Why?
| | Sex Factors | 12 | 2018 | 478 | 0.550 |
Why?
| | Mental Health | 2 | 2016 | 82 | 0.550 |
Why?
| | Cross-Sectional Studies | 14 | 2017 | 792 | 0.540 |
Why?
| | Emotions | 1 | 2012 | 88 | 0.530 |
Why?
| | Brain Diseases | 2 | 2013 | 65 | 0.510 |
Why?
| | Residence Characteristics | 9 | 2015 | 194 | 0.500 |
Why?
| | Muscle Strength | 6 | 2009 | 126 | 0.500 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2018 | 197 | 0.500 |
Why?
| | Knowledge | 1 | 2010 | 18 | 0.490 |
Why?
| | Telephone | 1 | 2010 | 31 | 0.490 |
Why?
| | Family Health | 1 | 2010 | 37 | 0.490 |
Why?
| | Diet | 4 | 2010 | 166 | 0.480 |
Why?
| | Time Factors | 14 | 2017 | 1741 | 0.480 |
Why?
| | Psychological Tests | 4 | 2013 | 65 | 0.470 |
Why?
| | Linear Models | 12 | 2017 | 255 | 0.460 |
Why?
| | Psychometrics | 11 | 2012 | 250 | 0.450 |
Why?
| | Clergy | 11 | 2013 | 70 | 0.440 |
Why?
| | Mental Status Schedule | 9 | 2017 | 123 | 0.440 |
Why?
| | Life | 2 | 2006 | 7 | 0.440 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 445 | 0.440 |
Why?
| | Cerebral Amyloid Angiopathy | 3 | 2015 | 79 | 0.440 |
Why?
| | Sclerosis | 3 | 2019 | 58 | 0.440 |
Why?
| | Blood Pressure | 4 | 2018 | 210 | 0.420 |
Why?
| | Antioxidants | 3 | 2005 | 64 | 0.410 |
Why?
| | Models, Psychological | 5 | 2015 | 87 | 0.410 |
Why?
| | Social Class | 2 | 2005 | 60 | 0.410 |
Why?
| | Language Tests | 2 | 2013 | 29 | 0.410 |
Why?
| | Social Support | 4 | 2014 | 197 | 0.400 |
Why?
| | Homes for the Aged | 1 | 2007 | 9 | 0.400 |
Why?
| | Parkinson Disease | 7 | 2017 | 1037 | 0.390 |
Why?
| | Logistic Models | 8 | 2017 | 457 | 0.390 |
Why?
| | Stroke | 3 | 2016 | 316 | 0.390 |
Why?
| | Nursing Homes | 1 | 2007 | 34 | 0.390 |
Why?
| | Feeding Behavior | 2 | 2005 | 113 | 0.380 |
Why?
| | Dietary Fats | 2 | 2006 | 40 | 0.380 |
Why?
| | Community Health Planning | 3 | 2011 | 21 | 0.380 |
Why?
| | Vitamin E | 3 | 2005 | 41 | 0.380 |
Why?
| | Intelligence | 1 | 2006 | 27 | 0.370 |
Why?
| | Risk Assessment | 10 | 2018 | 723 | 0.370 |
Why?
| | Decision Support Techniques | 1 | 2006 | 54 | 0.370 |
Why?
| | Smell | 2 | 2016 | 18 | 0.370 |
Why?
| | Personality Disorders | 1 | 2006 | 21 | 0.360 |
Why?
| | Mental Recall | 5 | 2014 | 66 | 0.360 |
Why?
| | Fish Products | 1 | 2005 | 2 | 0.360 |
Why?
| | Risk-Taking | 1 | 2006 | 40 | 0.360 |
Why?
| | Delusions | 1 | 2005 | 13 | 0.360 |
Why?
| | Fishes | 1 | 2005 | 5 | 0.350 |
Why?
| | TDP-43 Proteinopathies | 2 | 2017 | 55 | 0.350 |
Why?
| | Social Behavior | 5 | 2011 | 103 | 0.350 |
Why?
| | Factor Analysis, Statistical | 3 | 2015 | 67 | 0.340 |
Why?
| | Adult | 14 | 2015 | 8795 | 0.340 |
Why?
| | Diet Surveys | 2 | 2006 | 21 | 0.330 |
Why?
| | Reproducibility of Results | 7 | 2012 | 778 | 0.330 |
Why?
| | Genetic Variation | 3 | 2017 | 115 | 0.330 |
Why?
| | Mood Disorders | 1 | 2005 | 33 | 0.330 |
Why?
| | Hallucinations | 1 | 2005 | 93 | 0.330 |
Why?
| | Interviews as Topic | 1 | 2005 | 131 | 0.320 |
Why?
| | Space Perception | 2 | 2019 | 42 | 0.320 |
Why?
| | Self Report | 3 | 2015 | 176 | 0.310 |
Why?
| | Nutrition Disorders | 1 | 2003 | 10 | 0.310 |
Why?
| | Life Change Events | 2 | 2014 | 40 | 0.310 |
Why?
| | Personality Inventory | 4 | 2009 | 82 | 0.310 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2006 | 166 | 0.300 |
Why?
| | Child | 4 | 2013 | 1337 | 0.300 |
Why?
| | Continental Population Groups | 3 | 2010 | 100 | 0.300 |
Why?
| | Anger | 1 | 2003 | 29 | 0.300 |
Why?
| | Health Status | 7 | 2012 | 245 | 0.300 |
Why?
| | Affect | 1 | 2003 | 67 | 0.290 |
Why?
| | Movement Disorders | 3 | 2010 | 130 | 0.290 |
Why?
| | Gait Disorders, Neurologic | 5 | 2009 | 132 | 0.290 |
Why?
| | Diabetes Complications | 3 | 2016 | 56 | 0.290 |
Why?
| | Social Adjustment | 3 | 2009 | 32 | 0.290 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2016 | 306 | 0.290 |
Why?
| | Catholicism | 5 | 2013 | 21 | 0.290 |
Why?
| | Vitamin A | 1 | 2002 | 7 | 0.280 |
Why?
| | Carotenoids | 1 | 2002 | 10 | 0.280 |
Why?
| | Leg | 3 | 2007 | 46 | 0.280 |
Why?
| | Models, Statistical | 5 | 2016 | 136 | 0.280 |
Why?
| | Self Stimulation | 1 | 2002 | 12 | 0.270 |
Why?
| | Substantia Nigra | 3 | 2019 | 142 | 0.270 |
Why?
| | Statistics, Nonparametric | 4 | 2015 | 157 | 0.260 |
Why?
| | Reaction Time | 2 | 2015 | 107 | 0.260 |
Why?
| | tau Proteins | 4 | 2017 | 138 | 0.250 |
Why?
| | Epidemiologic Studies | 3 | 2012 | 24 | 0.250 |
Why?
| | Income | 2 | 2018 | 59 | 0.240 |
Why?
| | Socioeconomic Factors | 5 | 2018 | 323 | 0.240 |
Why?
| | Musculoskeletal Diseases | 2 | 2010 | 32 | 0.240 |
Why?
| | Synapses | 2 | 2012 | 44 | 0.240 |
Why?
| | Magnetic Resonance Imaging | 6 | 2018 | 1124 | 0.240 |
Why?
| | Prognosis | 4 | 2018 | 922 | 0.240 |
Why?
| | Muscle Rigidity | 3 | 2014 | 27 | 0.240 |
Why?
| | Prefrontal Cortex | 2 | 2019 | 132 | 0.230 |
Why?
| | Prevalence | 4 | 2018 | 497 | 0.230 |
Why?
| | Cardiovascular Diseases | 2 | 2017 | 316 | 0.230 |
Why?
| | Confidence Intervals | 7 | 2017 | 103 | 0.230 |
Why?
| | Smoking | 3 | 2012 | 170 | 0.230 |
Why?
| | Fraud | 1 | 2019 | 10 | 0.220 |
Why?
| | Antihypertensive Agents | 2 | 2018 | 65 | 0.220 |
Why?
| | Social Environment | 2 | 2012 | 86 | 0.220 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 8 | 0.220 |
Why?
| | Emergencies | 1 | 2019 | 36 | 0.220 |
Why?
| | Haplotypes | 2 | 2017 | 61 | 0.220 |
Why?
| | Primary Prevention | 1 | 2019 | 35 | 0.220 |
Why?
| | Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 27 | 0.220 |
Why?
| | Visual Perception | 2 | 2011 | 65 | 0.210 |
Why?
| | Parents | 2 | 2012 | 87 | 0.210 |
Why?
| | Economics | 1 | 2018 | 24 | 0.210 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 65 | 0.210 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 56 | 0.210 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 266 | 0.210 |
Why?
| | Blood Glucose | 1 | 2018 | 116 | 0.200 |
Why?
| | Odds Ratio | 6 | 2017 | 303 | 0.200 |
Why?
| | Predictive Value of Tests | 5 | 2018 | 584 | 0.200 |
Why?
| | Health Behavior | 2 | 2010 | 155 | 0.200 |
Why?
| | Osteoporosis | 1 | 2018 | 66 | 0.200 |
Why?
| | Gait | 5 | 2014 | 343 | 0.200 |
Why?
| | Urinary Incontinence | 1 | 2017 | 24 | 0.200 |
Why?
| | Neoplasms | 2 | 2018 | 237 | 0.200 |
Why?
| | Pain | 2 | 2010 | 280 | 0.200 |
Why?
| | Apolipoprotein E3 | 1 | 2017 | 10 | 0.190 |
Why?
| | Brain Infarction | 3 | 2016 | 67 | 0.190 |
Why?
| | Education | 3 | 2006 | 40 | 0.190 |
Why?
| | Homozygote | 1 | 2017 | 28 | 0.190 |
Why?
| | Delivery of Health Care | 1 | 2018 | 77 | 0.190 |
Why?
| | Polymorphism, Genetic | 1 | 2017 | 89 | 0.190 |
Why?
| | Gene Expression | 1 | 2018 | 259 | 0.190 |
Why?
| | Biostatistics | 1 | 2016 | 6 | 0.180 |
Why?
| | Prejudice | 2 | 2008 | 38 | 0.180 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 207 | 0.180 |
Why?
| | Employment | 1 | 2016 | 33 | 0.180 |
Why?
| | Statistics as Topic | 4 | 2017 | 123 | 0.180 |
Why?
| | Life Style | 4 | 2014 | 171 | 0.180 |
Why?
| | Age Distribution | 3 | 2011 | 116 | 0.170 |
Why?
| | Regression Analysis | 6 | 2018 | 307 | 0.170 |
Why?
| | Attention | 3 | 2005 | 145 | 0.170 |
Why?
| | Dentin | 2 | 2005 | 2 | 0.170 |
Why?
| | Age of Onset | 3 | 2013 | 107 | 0.160 |
Why?
| | Neurologic Examination | 2 | 2013 | 149 | 0.160 |
Why?
| | Empathy | 1 | 2014 | 37 | 0.160 |
Why?
| | Dancing | 1 | 2014 | 7 | 0.160 |
Why?
| | Harm Reduction | 1 | 2014 | 6 | 0.160 |
Why?
| | Cerebral Cortex | 1 | 2016 | 173 | 0.160 |
Why?
| | Raphe Nuclei | 1 | 2013 | 8 | 0.160 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 12 | 0.160 |
Why?
| | Locomotion | 1 | 2014 | 36 | 0.150 |
Why?
| | Religion | 1 | 2013 | 28 | 0.150 |
Why?
| | Cell Count | 1 | 2013 | 114 | 0.150 |
Why?
| | Financial Management | 1 | 2013 | 17 | 0.150 |
Why?
| | Cholinergic Antagonists | 1 | 2013 | 14 | 0.150 |
Why?
| | Social Isolation | 2 | 2018 | 24 | 0.150 |
Why?
| | Illinois | 4 | 2017 | 221 | 0.150 |
Why?
| | Medicare | 3 | 2019 | 80 | 0.150 |
Why?
| | Survival Analysis | 2 | 2005 | 370 | 0.150 |
Why?
| | Hypokinesia | 2 | 2014 | 23 | 0.150 |
Why?
| | Nerve Degeneration | 1 | 2013 | 54 | 0.150 |
Why?
| | Health Status Disparities | 1 | 2013 | 48 | 0.140 |
Why?
| | Religion and Psychology | 2 | 2010 | 25 | 0.140 |
Why?
| | Anomie | 1 | 2012 | 4 | 0.140 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2012 | 14 | 0.140 |
Why?
| | Patient Dropouts | 1 | 2012 | 31 | 0.140 |
Why?
| | Hydrocortisone | 1 | 2012 | 49 | 0.130 |
Why?
| | Health Promotion | 1 | 2014 | 162 | 0.130 |
Why?
| | Personality Assessment | 3 | 2006 | 40 | 0.130 |
Why?
| | Association | 1 | 2011 | 8 | 0.130 |
Why?
| | Choice Behavior | 1 | 2012 | 57 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2012 | 62 | 0.130 |
Why?
| | Young Adult | 3 | 2013 | 1961 | 0.130 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2012 | 60 | 0.130 |
Why?
| | Tremor | 2 | 2014 | 98 | 0.130 |
Why?
| | Post-Synaptic Density | 1 | 2011 | 2 | 0.130 |
Why?
| | Corticosterone | 1 | 2011 | 3 | 0.130 |
Why?
| | Population Surveillance | 3 | 2015 | 120 | 0.130 |
Why?
| | Receptors, Complement 3b | 1 | 2011 | 15 | 0.130 |
Why?
| | Microfilament Proteins | 1 | 2011 | 30 | 0.130 |
Why?
| | Endophenotypes | 1 | 2011 | 13 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2012 | 150 | 0.130 |
Why?
| | Wechsler Scales | 2 | 2010 | 15 | 0.130 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 35 | 0.130 |
Why?
| | Child, Preschool | 1 | 2013 | 724 | 0.120 |
Why?
| | Motor Skills Disorders | 1 | 2010 | 20 | 0.120 |
Why?
| | Diet, Mediterranean | 1 | 2010 | 27 | 0.120 |
Why?
| | CA3 Region, Hippocampal | 1 | 2010 | 6 | 0.120 |
Why?
| | Genetic Association Studies | 3 | 2017 | 81 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 1 | 2010 | 23 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 127 | 0.120 |
Why?
| | HIV Infections | 1 | 2017 | 829 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2011 | 194 | 0.110 |
Why?
| | Life Expectancy | 1 | 2009 | 19 | 0.110 |
Why?
| | Somatosensory Disorders | 1 | 2009 | 10 | 0.110 |
Why?
| | Self Care | 1 | 2010 | 104 | 0.110 |
Why?
| | Sensory Thresholds | 1 | 2009 | 25 | 0.110 |
Why?
| | Hostility | 1 | 2009 | 22 | 0.110 |
Why?
| | Immunohistochemistry | 4 | 2017 | 484 | 0.110 |
Why?
| | Adolescent | 2 | 2013 | 2381 | 0.110 |
Why?
| | Financing, Personal | 2 | 2019 | 19 | 0.110 |
Why?
| | Vibration | 1 | 2009 | 30 | 0.110 |
Why?
| | Amyloid | 2 | 2010 | 42 | 0.110 |
Why?
| | Caspase 3 | 1 | 2008 | 31 | 0.110 |
Why?
| | Differential Threshold | 1 | 2008 | 3 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2005 | 20 | 0.110 |
Why?
| | Acid Etching, Dental | 2 | 2005 | 3 | 0.100 |
Why?
| | Hemoglobins | 1 | 2008 | 75 | 0.100 |
Why?
| | Retrospective Studies | 2 | 2013 | 2805 | 0.100 |
Why?
| | Survival Rate | 1 | 2009 | 419 | 0.100 |
Why?
| | Data Collection | 2 | 2005 | 117 | 0.100 |
Why?
| | Hand Strength | 1 | 2007 | 43 | 0.100 |
Why?
| | Personal Space | 1 | 2007 | 7 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 98 | 0.100 |
Why?
| | Perceptual Disorders | 1 | 2006 | 6 | 0.100 |
Why?
| | Latin America | 1 | 2006 | 6 | 0.100 |
Why?
| | Likelihood Functions | 2 | 2017 | 32 | 0.090 |
Why?
| | Trans Fatty Acids | 1 | 2006 | 4 | 0.090 |
Why?
| | Copper | 1 | 2006 | 10 | 0.090 |
Why?
| | Spouses | 1 | 2006 | 28 | 0.090 |
Why?
| | Dyskinesias | 1 | 2006 | 27 | 0.090 |
Why?
| | Fatty Acids | 1 | 2006 | 40 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2006 | 35 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2006 | 73 | 0.090 |
Why?
| | Fear | 1 | 2006 | 48 | 0.090 |
Why?
| | Psychology | 1 | 2006 | 18 | 0.090 |
Why?
| | Data Interpretation, Statistical | 3 | 2016 | 93 | 0.090 |
Why?
| | Urban Health | 1 | 2006 | 27 | 0.090 |
Why?
| | Population Groups | 1 | 2005 | 4 | 0.090 |
Why?
| | Parent-Child Relations | 1 | 2006 | 33 | 0.090 |
Why?
| | Patient Readmission | 1 | 2007 | 101 | 0.090 |
Why?
| | Verbal Learning | 2 | 2004 | 39 | 0.090 |
Why?
| | Parkinson Disease, Secondary | 1 | 2005 | 28 | 0.090 |
Why?
| | Molar, Third | 1 | 2005 | 1 | 0.090 |
Why?
| | Dentin-Bonding Agents | 1 | 2005 | 1 | 0.090 |
Why?
| | Dental Etching | 1 | 2005 | 1 | 0.090 |
Why?
| | Parenting | 1 | 2006 | 57 | 0.090 |
Why?
| | Tocopherols | 1 | 2005 | 5 | 0.090 |
Why?
| | Eating | 1 | 2005 | 51 | 0.080 |
Why?
| | Family Characteristics | 1 | 2005 | 17 | 0.080 |
Why?
| | DNA | 1 | 2005 | 143 | 0.080 |
Why?
| | Energy Intake | 1 | 2005 | 85 | 0.080 |
Why?
| | Water | 1 | 2005 | 36 | 0.080 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 33 | 0.080 |
Why?
| | Tooth Demineralization | 1 | 2004 | 2 | 0.080 |
Why?
| | Sex Distribution | 3 | 2011 | 87 | 0.080 |
Why?
| | Postural Balance | 3 | 2014 | 108 | 0.080 |
Why?
| | Heterozygote | 2 | 2015 | 97 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2010 | 583 | 0.080 |
Why?
| | Markov Chains | 2 | 2015 | 32 | 0.080 |
Why?
| | Seafood | 1 | 2003 | 13 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 349 | 0.080 |
Why?
| | Brief Psychiatric Rating Scale | 2 | 2015 | 9 | 0.070 |
Why?
| | Sleep | 1 | 2006 | 272 | 0.070 |
Why?
| | Brain Mapping | 3 | 2012 | 180 | 0.070 |
Why?
| | Health Surveys | 2 | 2013 | 92 | 0.070 |
Why?
| | Frontal Lobe | 1 | 2002 | 84 | 0.070 |
Why?
| | Interview, Psychological | 2 | 2014 | 45 | 0.060 |
Why?
| | Cerebrovascular Disorders | 2 | 2013 | 86 | 0.060 |
Why?
| | Intelligence Tests | 2 | 2014 | 16 | 0.060 |
Why?
| | Animals | 2 | 2011 | 4877 | 0.060 |
Why?
| | Body Mass Index | 2 | 2016 | 383 | 0.060 |
Why?
| | Nutrition Assessment | 3 | 2005 | 52 | 0.060 |
Why?
| | Blotting, Western | 2 | 2011 | 236 | 0.060 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2019 | 19 | 0.060 |
Why?
| | Proteomics | 1 | 2019 | 47 | 0.050 |
Why?
| | Muscle Strength Dynamometer | 2 | 2009 | 16 | 0.050 |
Why?
| | Religious Personnel | 1 | 2018 | 11 | 0.050 |
Why?
| | Epidemiologic Research Design | 2 | 2010 | 16 | 0.050 |
Why?
| | Dementia, Vascular | 1 | 2018 | 40 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2018 | 136 | 0.050 |
Why?
| | Genetic Linkage | 1 | 2017 | 42 | 0.050 |
Why?
| | Diagnosis | 1 | 2017 | 24 | 0.050 |
Why?
| | Genotyping Techniques | 1 | 2017 | 11 | 0.050 |
Why?
| | Tuberous Sclerosis | 1 | 2017 | 14 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2018 | 514 | 0.050 |
Why?
| | White Matter | 1 | 2018 | 95 | 0.050 |
Why?
| | Arteriolosclerosis | 1 | 2016 | 33 | 0.050 |
Why?
| | Anisotropy | 1 | 2016 | 49 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 60 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2016 | 72 | 0.040 |
Why?
| | Demography | 1 | 2016 | 80 | 0.040 |
Why?
| | Inflammation | 1 | 2018 | 300 | 0.040 |
Why?
| | Pattern Recognition, Visual | 2 | 2005 | 36 | 0.040 |
Why?
| | Hardness | 2 | 2005 | 6 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 225 | 0.040 |
Why?
| | Elasticity | 2 | 2005 | 55 | 0.040 |
Why?
| | Computer Simulation | 1 | 2016 | 220 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2015 | 94 | 0.040 |
Why?
| | Surface Properties | 2 | 2005 | 131 | 0.040 |
Why?
| | Self Efficacy | 1 | 2014 | 55 | 0.040 |
Why?
| | Materials Testing | 2 | 2005 | 132 | 0.040 |
Why?
| | Medicare Part D | 1 | 2013 | 7 | 0.040 |
Why?
| | ROC Curve | 1 | 2014 | 128 | 0.040 |
Why?
| | Dietary Supplements | 2 | 2005 | 52 | 0.040 |
Why?
| | Reference Values | 2 | 2004 | 248 | 0.040 |
Why?
| | Executive Function | 1 | 2013 | 87 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 256 | 0.040 |
Why?
| | Databases, Factual | 1 | 2014 | 314 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2012 | 16 | 0.040 |
Why?
| | Protein Array Analysis | 1 | 2012 | 11 | 0.040 |
Why?
| | Phosphoserine | 1 | 2012 | 5 | 0.030 |
Why?
| | Cerebellar Cortex | 1 | 2012 | 6 | 0.030 |
Why?
| | Multilevel Analysis | 1 | 2012 | 7 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2012 | 32 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2012 | 32 | 0.030 |
Why?
| | Aniline Compounds | 1 | 2012 | 37 | 0.030 |
Why?
| | Models, Genetic | 1 | 2012 | 36 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 41 | 0.030 |
Why?
| | Thiazoles | 1 | 2012 | 39 | 0.030 |
Why?
| | Drug Resistance | 1 | 2012 | 62 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 4 | 0.030 |
Why?
| | Glucose | 1 | 2012 | 59 | 0.030 |
Why?
| | Causality | 1 | 2011 | 48 | 0.030 |
Why?
| | Temporal Lobe | 1 | 2012 | 100 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 38 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 85 | 0.030 |
Why?
| | Phosphorylation | 1 | 2012 | 189 | 0.030 |
Why?
| | Niacinamide | 1 | 2011 | 5 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2012 | 296 | 0.030 |
Why?
| | Insulin | 1 | 2012 | 95 | 0.030 |
Why?
| | Trail Making Test | 1 | 2010 | 3 | 0.030 |
Why?
| | Wine | 1 | 2010 | 6 | 0.030 |
Why?
| | Nutrition Policy | 1 | 2010 | 12 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2012 | 159 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2010 | 11 | 0.030 |
Why?
| | Dendrites | 1 | 2010 | 14 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2011 | 362 | 0.030 |
Why?
| | Retirement | 1 | 2009 | 11 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2010 | 41 | 0.030 |
Why?
| | Piperazines | 1 | 2011 | 93 | 0.030 |
Why?
| | Internet | 1 | 2011 | 84 | 0.030 |
Why?
| | Mechanoreceptors | 1 | 2009 | 8 | 0.030 |
Why?
| | Proprioception | 1 | 2009 | 21 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 486 | 0.030 |
Why?
| | Synaptosomes | 1 | 2008 | 4 | 0.030 |
Why?
| | Tissue Extracts | 1 | 2008 | 15 | 0.030 |
Why?
| | Ergometry | 1 | 2008 | 3 | 0.030 |
Why?
| | Patient Compliance | 1 | 2010 | 193 | 0.030 |
Why?
| | Protein Transport | 1 | 2008 | 42 | 0.030 |
Why?
| | Cytosol | 1 | 2008 | 61 | 0.030 |
Why?
| | Signal Transduction | 1 | 2012 | 529 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2008 | 93 | 0.030 |
Why?
| | Joints | 1 | 2009 | 101 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2008 | 143 | 0.030 |
Why?
| | Algorithms | 1 | 2011 | 384 | 0.030 |
Why?
| | Cause of Death | 1 | 2008 | 64 | 0.030 |
Why?
| | Observation | 1 | 2007 | 16 | 0.020 |
Why?
| | Aspirin | 1 | 2008 | 72 | 0.020 |
Why?
| | Visual Acuity | 1 | 2007 | 45 | 0.020 |
Why?
| | Psychotropic Drugs | 1 | 2007 | 29 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2010 | 628 | 0.020 |
Why?
| | Forecasting | 1 | 2006 | 127 | 0.020 |
Why?
| | Verbal Behavior | 1 | 2005 | 23 | 0.020 |
Why?
| | Mice | 1 | 2011 | 1684 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2005 | 39 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2005 | 51 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 337 | 0.020 |
Why?
| | Community Mental Health Centers | 1 | 2005 | 5 | 0.020 |
Why?
| | Cultural Diversity | 1 | 2005 | 26 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 44 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2005 | 10 | 0.020 |
Why?
| | Cementation | 1 | 2005 | 29 | 0.020 |
Why?
| | gamma-Tocopherol | 1 | 2005 | 8 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 9 | 0.020 |
Why?
| | Gene Frequency | 1 | 2005 | 82 | 0.020 |
Why?
| | Logic | 1 | 2004 | 3 | 0.020 |
Why?
| | Dentin Permeability | 1 | 2004 | 1 | 0.020 |
Why?
| | Phosphoric Acids | 1 | 2004 | 1 | 0.020 |
Why?
| | Resin Cements | 1 | 2004 | 1 | 0.020 |
Why?
| | Phase Transition | 1 | 2004 | 2 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2004 | 10 | 0.020 |
Why?
| | Desiccation | 1 | 2004 | 5 | 0.020 |
Why?
| | Comprehension | 1 | 2004 | 30 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2005 | 244 | 0.020 |
Why?
| | Cues | 1 | 2004 | 74 | 0.020 |
Why?
| | Sick Role | 1 | 2004 | 15 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2005 | 82 | 0.020 |
Why?
| | Heart Failure | 1 | 2007 | 184 | 0.020 |
Why?
| | Speech Perception | 1 | 2004 | 51 | 0.020 |
Why?
| | Probability | 1 | 2004 | 96 | 0.020 |
Why?
| | Sampling Studies | 1 | 2003 | 32 | 0.020 |
Why?
| | Eicosapentaenoic Acid | 1 | 2003 | 8 | 0.020 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 10 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2003 | 12 | 0.020 |
Why?
| | Walking | 1 | 2005 | 197 | 0.020 |
Why?
| | beta Carotene | 1 | 2002 | 14 | 0.020 |
Why?
| | Ascorbic Acid | 1 | 2002 | 37 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2002 | 52 | 0.020 |
Why?
| | Hypotension | 1 | 2002 | 28 | 0.020 |
Why?
| | Dominance, Cerebral | 1 | 2002 | 24 | 0.020 |
Why?
| | Semantics | 1 | 2002 | 24 | 0.020 |
Why?
| | Arousal | 1 | 2002 | 54 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2002 | 122 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2002 | 367 | 0.020 |
Why?
| | Hypertension | 1 | 2002 | 218 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|